Correlation Between Marker Therapeutics and Anebulo Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Marker Therapeutics and Anebulo Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Marker Therapeutics and Anebulo Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Marker Therapeutics and Anebulo Pharmaceuticals, you can compare the effects of market volatilities on Marker Therapeutics and Anebulo Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Marker Therapeutics with a short position of Anebulo Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Marker Therapeutics and Anebulo Pharmaceuticals.
Diversification Opportunities for Marker Therapeutics and Anebulo Pharmaceuticals
-0.33 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Marker and Anebulo is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding Marker Therapeutics and Anebulo Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Anebulo Pharmaceuticals and Marker Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Marker Therapeutics are associated (or correlated) with Anebulo Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Anebulo Pharmaceuticals has no effect on the direction of Marker Therapeutics i.e., Marker Therapeutics and Anebulo Pharmaceuticals go up and down completely randomly.
Pair Corralation between Marker Therapeutics and Anebulo Pharmaceuticals
Given the investment horizon of 90 days Marker Therapeutics is expected to generate 1.05 times more return on investment than Anebulo Pharmaceuticals. However, Marker Therapeutics is 1.05 times more volatile than Anebulo Pharmaceuticals. It trades about 0.04 of its potential returns per unit of risk. Anebulo Pharmaceuticals is currently generating about 0.02 per unit of risk. If you would invest 347.00 in Marker Therapeutics on September 12, 2024 and sell it today you would earn a total of 51.00 from holding Marker Therapeutics or generate 14.7% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Marker Therapeutics vs. Anebulo Pharmaceuticals
Performance |
| Timeline |
| Marker Therapeutics |
| Anebulo Pharmaceuticals |
Marker Therapeutics and Anebulo Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Marker Therapeutics and Anebulo Pharmaceuticals
The main advantage of trading using opposite Marker Therapeutics and Anebulo Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Marker Therapeutics position performs unexpectedly, Anebulo Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Anebulo Pharmaceuticals will offset losses from the drop in Anebulo Pharmaceuticals' long position.| Marker Therapeutics vs. Lumos Pharma | Marker Therapeutics vs. Exicure | Marker Therapeutics vs. Protagenic Therapeutics | Marker Therapeutics vs. Pmv Pharmaceuticals |
| Anebulo Pharmaceuticals vs. Adagene | Anebulo Pharmaceuticals vs. Acrivon Therapeutics, Common | Anebulo Pharmaceuticals vs. AnaptysBio | Anebulo Pharmaceuticals vs. Mineralys Therapeutics, Common |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Complementary Tools
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |